A New Course for Fighting Inflammation

Hyperinflammation, or the cytokine storm, can be devastating to critically ill patients. Critical care professionals have long fought the effects of hyperinflammation in patients, and the COVID-19 pandemic has made knowledge of the cytokine storm more prevalent. Today we have more information on the impact of the cytokine storm on organs, including the lungs, heart and kidneys. In the cytokine storm, hyperinflammation spreads uncontrollably, inevitably leading to endothelial dysfunction and subsequent organ damage.

SeaStar Medical is charting a new course to stop the cytokine storm.

SeaStar Medical is a clinical-stage company fighting the consequences of hyperinflammation in vital organs. In development is our Selective Cytopheretic Device (SCD), a patented, next-level immunomodulator that selectively targets hyperactive neutrophils and monocytes to reparative physiology and help the body heal. The SCD has the potential to eliminate dialysis dependency and get patients out of the ICU faster.

We understand that developing ICU therapies requires a deep understanding of the challenges that critical care team members experience daily. This is why our team consists of medical and scientific professionals including Matt Jacques, RN, our Clinical Account Nurse Manager. Among his many roles, he implements education and training our SCD device trial sites.

Before becoming a full-time member of the SeaStar Medical team, Matt worked as a critical care nurse for 8 years, with the last 3.5 years in the Intensive Care Unit. “The ICU level, being the highest level of care,” said Jacques, “It is different than any other nursing floor in the hospital. The doctor and nurse interactions are different, and the responsibilities for their patients are much higher.” This on-the-ground experience gives SeaStar Medical first-hand knowledge of the challenges that critical care nurses and doctors experience daily.

Having the perspective of critical care nurses and doctors supports SeaStar Medical’s product development, ensuring that our solutions help critical care nurses, doctors and their patients. “Having the knowledge of the ICU,” Jacques added, “and working directly with doctors and nurses to overcome challenges helps guide our entire process from how we launch products to how we train on them.”

Today we launch a blog to share insights about fighting inflammation in acute and chronic settings. As we study the science, we would like to share our learnings and observations with you. We hope to continue to help the doctors and nurses on the ground who are fighting the cytokine storm every day.

If you would like to receive our blogs in your inbox, please complete the form below. We promise we will not spam you.

To learn more about our science, visit our website.

Leave a Comment